LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
5.45
-0.15 (-2.68%)
At close: Mar 28, 2025, 4:00 PM
5.31
-0.15 (-2.66%)
Pre-market: Mar 31, 2025, 8:56 AM EDT
LifeMD Market Cap
LifeMD has a market cap or net worth of $242.98 million as of March 31, 2025. Its market cap has decreased by -32.37% in one year.
Market Cap
242.98M
Enterprise Value
233.08M
1-Year Change
-32.37%
Ranking
Category
Stock Price
$5.45
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $242.98M, an increase of 6,842.32%. That is a compound annual growth rate of 42.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 243.00M | 13.34% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |